Wed Sep 6, 2023 – 4:25 pm EDT
WASHINGTON, D.C. (LifeSiteNews) — Updated booster shots are anticipated to gain FDA approval and hit the market as soon as next week. The news comes amid reports of renewed COVID-related measures and worries that full-scale mandates could make a pre-election comeback.
ABC News reported that the U.S. Food and Drug Administration (FDA) is likely to greenlight injections, which are reportedly formulated to target the XBB.1.5. variant of the coronavirus, a subvariant of omicron. Officials also argue it will be effective against the most recently observed strain, known as BA.2.86.
On September 12, an advisory panel for the U.S. Centers for Disease Control and Prevention (CDC) is set to consider their vaccination recommendations based upon eligibility.
“The CDC director is expected to sign off, with shots to be available soon after,” ABC reported.
The jabs are anticipated to hit the market as early as September 13.
The news comes after U.S. President Joe Biden said late last month that he was asking Congress to fund the development of the new COVID-19 jab.
Shortly thereafter, White House Press Secretary Karine Jean-Pierre spoke to reporters about the updated COVID shot and confirmed
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
